TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.25-CA$0.50 (-1.74%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.98% below the high.
Loading market information…
CNQ · MCUR.CN · CAD
Stock price, earnings
Quote as of Nov 18, 2022, 03:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Mind Cure Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mind Cure Health Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mind Cure Health Inc. operates as a life sciences firm, dedicated to creating and marketing mental health and wellness solutions across North America. The company's strategy revolves around advancing digital therapeutic technologies and exploring psychedelic compounds, with the goal of rapidly expanding access to scientifically validated, evidence-based mental health treatments. Among its key innovations is iSTRYM, a unique digital therapeutic software application designed to enhance the entire healing journey for patients and clinicians throughout all phases of therapy. It also offers PsyCollage, a bioinformatics platform crucial for guiding research by identifying priority programs. Furthermore, Mind Cure Health produces synthetic ibogaine for distribution to researchers and clinicians, and investigates various psychedelic compounds, particularly ibogaine, for its potential in treating traumatic brain injuries and related conditions. Established in 2020, Mind Cure Health Inc. maintains its headquarters in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.25-CA$0.50 (-1.74%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.98% below the high.
CA$0.14CA$0.00 (0.0%)
Lynx Resources Corp.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
CA$0.05CA$0.00 (0.0%)
PharmaCielo Ltd.’s quoted price sits in the lower half of its reported 52-week range, 69.7% below the high.
CA$0.09CA$0.00 (0.0%)
Telecure Technologies Inc.: Healthcare · Medical - Healthcare Information Services.
CA$0.06CA$0.00 (0.0%)
Tryp Therapeutics Inc.: Healthcare · Biotechnology.
$5.93+$0.08 (+1.37%)
Clearmind Medicine Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.78% below the high.
CA$0.10-CA$0.04 (-25.93%)
Awakn Life Sciences Corp.: Healthcare · Biotechnology.
CA$0.10CA$0.00 (0.0%)
Asep Medical Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
